In conclusion, to our knowledge, our study provided the first evidence that high expression of NDRG1 in bladder cancer patients is associated with advanced tumour stage and poor outcomes and could be a diagnostic and prognostic biomarker. The gene discussed is NDRG1; the disease is urinary bladder carcinoma.